Internal Medicine, Gastroenterology · Richmond, TX
NPI
1093854010
Since 2007
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
6
Hospital affiliations
1601 Main St Ste 401
Richmond, TX, 77469
Phone (281) 342-9530
Groups this clinician bills Medicare through
Medicare paid, 2024
$219K
2,506 services
Medicare patients, 2024
957
Average age 73
Drug cost, 2024
$432K
1,634 prescriptions
Company payments, 2025
$2,126
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nitesh Vachhani was code 99232 (hospital e&m - subsequent), 584 times for 257 patients. In total Nitesh Vachhani billed 2,506 services in 42 codes, and Medicare paid $219K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-08-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 584 | 257 | $58.83 | $34K |
| 99214 Office E&M - Established | Office | 224 | 184 | $87.36 | $20K |
| 99222 Hospital E&M - Initial | Facility | 209 | 197 | $97.19 | $20K |
| 99213 Office E&M - Established | Office | 209 | 179 | $63.22 | $13K |
| 45385 Colonoscopy - Lesion Removal | Facility | 161 | 156 | $193.23 | $31K |
| 45380 Lower GI Endoscopy - Other | Facility | 147 | 147 | $73.80 | $11K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 139 | 37 | $47.51 | $6,603 |
| 99204 Office E&M - New | Office | 138 | 138 | $98.80 | $14K |
| 43239 Upper GI Endoscopy | Facility | 133 | 130 | $71.26 | $9,478 |
| 99203 Office E&M - New | Office | 107 | 107 | $72.39 | $7,746 |
| 43246 Upper GI Endoscopy | Facility | 69 | 64 | $149.82 | $10K |
| 99223 Hospital E&M - Initial | Facility | 64 | 64 | $130.73 | $8,367 |
| 99233 Hospital E&M - Subsequent | Facility | 49 | 32 | $89.64 | $4,392 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 47 | 22 | $36.30 | $1,706 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 41 | 41 | $172.03 | $7,053 |
By year: 2022 $244K for 3,332 services; 2023 $248K for 3,393 services; 2024 $219K for 2,506 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nitesh Vachhani prescribed most often to Medicare patients was Pantoprazole Sodium, with 343 prescriptions and refills. In total Nitesh Vachhani wrote 1,634 Medicare prescriptions that cost $432K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 343 | 656 | 123 | $2,783 |
| Famotidine Generic | 302 | 489 | 93 | $2,076 |
| Linzess Linaclotide | 147 | 211 | 54 | $110K |
| Plenvu Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 123 | 123 | 119 | $17K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 113 | 113 | 113 | $6,889 |
| Dicyclomine Hcl Generic | 73 | 102 | 36 | $1,308 |
| Ondansetron Odt Ondansetron | 52 | 52 | 20 | $558 |
| Omeprazole Generic | 51 | 129 | 23 | $1,077 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 42 | 42 | 42 | $7,229 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 30 | 30 | 29 | $368 |
| Zenpep Lipase/Protease/Amylase | 25 | 28 | Under 11 | $65K |
| Sucralfate Generic | 23 | 23 | 11 | $3,239 |
| Furosemide Generic | 17 | 21 | Under 11 | $59.22 |
| Spironolactone Generic | 17 | 33 | Under 11 | $341 |
| Lactulose Generic | 17 | 20 | Under 11 | $494 |
Brand drugs: 481 claims; generic drugs: 1,153 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nitesh Vachhani $2,126 ($2,126 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $895.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 49 | $895 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 35 | $293 |
| Janssen Biotech, Inc. JNJ | 9 | $185 |
| Vivus LLC | 7 | $160 |
| Madrigal Pharmaceuticals MDGL | 6 | $123 |
| Pfizer Inc. PFE | 4 | $85.55 |
| Aimmune Therapeutics, Inc. | 4 | $74.66 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $61.26 |
| Novo Nordisk Inc NVO | 2 | $48.48 |
| Ardelyx, Inc. ARDX | 2 | $40.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.